16/12/2024
Development of novel therapies in a pre-clinical setting.
Creation and validation of predictive and pharmacodynamic biomarkers.
Replication of pre-clinical findings to enhance reliability.
Pre-clinical proof-of-concept studies for therapy readiness.
